ParvOryx
AXP000127.1 · Oncolytic virus
- Platform
- parvovirus H-1 (H-1PV, wild-type)
- Originator
- German Cancer Research Center (DKFZ)
- Sponsor
- Oryx GmbH
Names
Virus
- Role
- Oncolytic
- Family
- Parvoviridae
- Virus
- H-1 parvovirus (NCBI Taxonomy 10799)
- Strain
- H-1PV (wild-type)
- Replication
- replicating
- Modifications
- none (wild-type)
- Route
- intratumoral, intravenous, intracerebral
- Source
- evidence
Cross-references
- NCI Thesaurus
- C96229
Approvals
No regulatory approval recorded.
Clinical trials (2)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT02653313 | Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer | Completed | Phase 1/2 | 2015-12 | 2018-05 | 7 | Carcinoma, Pancreatic Ductal |
| NCT01301430 | Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme. | Completed | Phase 1/2 | 2011-09 | 2015-05 | 18 | Glioblastoma Multiforme |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 34426438 | Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma. | Clinical cancer research : an official journal of the American Association for Cancer Research | 2021 | name in abstract: ParvOryx |
| PMID 28851316 | A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol. | BMC cancer | 2017 | name in title: ParvOryx |
| PMID 22436661 | Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol. | BMC cancer | 2012 | name in title: ParvOryx |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 34004331 | Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme. | Seminars in cancer biology | 2022 | name in abstract: ParvOryx |
| PMID 31486047 | Fluorescence In Situ Hybridization (FISH) Detection of Viral Nucleic Acids in Oncolytic H-1 Parvovirus-Treated Human Brain Tumors. | Methods in molecular biology (Clifton, N.J.) | 2020 | name in abstract: ParvOryx |
| PMID 30563098 | Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy? | Cancers | 2018 | name in abstract: ParvOryx |
| PMID 22642177 | [Oncolytic parvoviruses. A new approaches for cancer therapy]. | Vestnik Rossiiskoi akademii meditsinskikh nauk | 2012 | name in abstract: ParvOryx |
Unconfirmed matches (16)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 34071585 | Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer. | Viruses | 2021 | name in title: H-1PV |
| PMID 31440242 | Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study. | Frontiers in immunology | 2019 | name in title: H-1PV |
| PMID 29584637 | Mutations in the Non-Structural Protein-Coding Sequence of Protoparvovirus H-1PV Enhance the Fitness of the Virus and Show Key Benefits Regarding the Transduction Efficiency of Derived Vectors. | Viruses | 2018 | name in title: H-1PV |
| PMID 29039746 | Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro. | Viruses | 2017 | name in title: H-1PV |
| PMID 26658622 | Standardized large-scale H-1PV production process with efficient quality and quantity monitoring. | Journal of virological methods | 2016 | name in title: H-1PV |
| PMID 24574398 | Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer. | Journal of virology | 2014 | name in title: H-1PV |
| PMID 23383065 | TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells. | PloS one | 2013 | name in title: H-1PV |
| PMID 24092664 | Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas. | EMBO molecular medicine | 2013 | name in title: H-1PV |
| PMID 24210118 | Capacity of wild-type and chemokine-armed parvovirus H-1PV for inhibiting neo-angiogenesis. | Virology | 2013 | name in title: H-1PV |
| PMID 22258256 | Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid. | Journal of virology | 2012 | name in title: H-1PV |
| PMID 22553326 | An in-frame deletion in the NS protein-coding sequence of parvovirus H-1PV efficiently stimulates export and infectivity of progeny virions. | Journal of virology | 2012 | name in title: H-1PV |
| PMID 22024742 | Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer. | Cancer biology & therapy | 2011 | name in title: H-1PV |
| PMID 19856310 | SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV. | International journal of cancer | 2010 | name in title: H-1PV |
| PMID 21124075 | Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent. | Cancer biology & therapy | 2010 | name in title: H-1PV |
| PMID 19147756 | Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV. | Clinical cancer research : an official journal of the American Association for Cancer Research | 2009 | name in title: H-1PV |
| PMID 19367260 | Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies. | Molecular therapy : the journal of the American Society of Gene Therapy | 2009 | name in title: H-1PV |
Notes
Wild-type rat protoparvovirus H-1, unmodified. ParvOryx01 in glioblastoma used intratumoral/intracerebral and intravenous/intracerebral arms; ParvOryx02 treated pancreatic carcinoma. The only non-adenovirus, non-herpes, non-pox DNA virus found dosed in humans as an oncolytic.
How to cite
ParvOryx (AXP000127.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000127.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.